QDENGA Dengue Vaccine to Hit India Market in 2027; Dr Reddy’s to Sell It

Dr Reddy’s to distribute Qdenga, India’s first dengue vaccine

The Takeda vaccine, Qdenga, is likely to be introduced in India in the first half of 2027 and the price has not yet been decided

Dr. Reddy's, Takeda Pharma ink pact to distribute India's first dengue vaccine QDENGA

Dr. Reddy's and Takeda partner to distribute India's first dengue vaccine, QDENGA, expected in early 2027

Dr Reddy’s to distribute India’s first dengue vaccine Qdenga in 2027

Company to exclusively promote and distribute Takeda’s vaccine for people aged 4–60; launch expected in the first half of 2027 subject to regulatory and quality clearances

Takeda and Dr. Reddy’s Laboratories Enter into Exclusive Collaboration to Promote and Distribute QDENGA® in India’s Pediatric and Adult Private Market

Get latest articles and stories on India at LatestLY. Takeda Pharmaceutical Company Limited, through its Indian subsidiary Takeda Biopharmaceuticals India Private Limited (together referred to as “Takeda”) and Dr Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr Reddy’s”) today entered into a distribution agreement under which Dr Reddy’s will promote and dis…

Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine

Takeda’s Qdenga dengue vaccine to be distributed in India by Dr Reddy’s in 2027

Takeda’s two-dose dengue vaccine has been approved by CDSCO for people aged 4-60 and is expected to enter India’s private market in the first half of 2027.